[1]
Theotokoglou, S. et al. 2025. Efficacy of Bimekizumab in the Management of Refractory Erythrodermic Pityriasis Rubra Pilaris: Clinical Insights. Dermatology Practical & Conceptual. 15, 3 (Jul. 2025), 5316. DOI:https://doi.org/10.5826/dpc.1503a5316.